The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
among universities worldwide for producing undergrad entrepreneurs
in Israel and Europe for research on artificial intelligence
in Europe and #21 in the world for aerospace engineering
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
In the ongoing fight against cancer, Technion breakthroughs in diagnostics and treatments have improved and saved lives around the world. This year alone, scientists at the Rappaport Technion Integrated Cancer Center (RTICC) have advanced research on early detection of various cancers, curbing cancer metastasis, and personalized treatment.
RTICC donors enjoyed an exclusive look at the cutting-edge work they were instrumental in promoting.
Panelists discussed:
There was a 15-minute Q&A session following the discussion.
The webinar was moderated by Sara Crown Star, a member of the Crown family of Chicago, prominent supporters of the RTICC.
Associate Professor Asya Rolls heads a lab in the Rappaport Faculty of Medicine that investigates the physiological mechanisms whereby emotions and thoughts affect health. For example, her laboratory showed that the release of the “feel-good neurotransmitter” dopamine disabled tumor-promoting cells in the immune system of mice, allowing them to fight cancer.
Professor Irit Ben-Aharon is director of the Division of Oncology at Rambam Health Care Campus, which is affiliated with the Technion and is the largest cancer center in northern Israel. She earned her M.D. and Ph.D. at a joint program of Tel Aviv University and the National Institutes of Health. Her research focuses on the toxic effects of chemotherapy on fertility, and on the fetus during pregnancy.
November 09, 2020
Learn about the important work of the Rappaport Technion Integrated Cancer Center (RTICC), including research to detect various cancers.
2 mins
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
Why do so many life-saving technologies never make it out of the lab? Prof. Marcelle Machluf demonstrates how combining scientific rigor with business vision is the only way to bring practical solutions to the patients who need them most. As a case in point, she shares her personal transformation from researcher to entrepreneur. This talk […]
Can the future of nutrition be more personalized, even down to our biology? A new study from the Technion suggests it can. Researchers in the Faculty of Biotechnology and Food Engineering recently discovered that men and women digest milk and plant-based milk alternatives differently — a breakthrough that could have far-reaching implications for nutrition science, […]
This op-ed is authored by Jenny Goldstein, chief development officer of the American Technion Society. For anyone who has faced a cancer diagnosis, or watched someone they love go through one, there is a particular anguish that comes with uncertainty. For me, that feeling is deeply personal. My father, an engineer whose love of science […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.